{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:05:32Z","timestamp":1790370332295,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["NICHD U54 HD061221"],"award-info":[{"award-number":["NICHD U54 HD061221"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001204","name":"Kettering Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001204","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymgme.2026.110257","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:27:53Z","timestamp":1788733673000},"page":"110257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A brief history of gene therapy for ornithine transcarbamylase deficiency"],"prefix":"10.1016","volume":"149","author":[{"given":"Margo Sheck","family":"Breilyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Konczal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary O.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110257_bb0005","series-title":"Mendel\u2019s Principles of Heredity","author":"Bateson","year":"1902"},{"key":"10.1016\/j.ymgme.2026.110257_bb0010","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/S0140-6736(01)41972-6","article-title":"The incidence of alkaptonuria: a study in chemical individuality","volume":"ii","author":"Garrod","year":"1902","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2026.110257_bb0015","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1126\/science.129.3365.1711","article-title":"A case history in biological research","volume":"129","author":"Tatum","year":"1959","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2026.110257_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1353\/pbm.1966.0027","article-title":"Molecular biology, nucleic acids, and the future of medicine","volume":"10","author":"Tatum","year":"1966","journal-title":"Perspect. Biol. Med."},{"key":"10.1016\/j.ymgme.2026.110257_bb0025","series-title":"Proceedings of the Sixth World Congress on Fertility and Sterility","first-page":"18","article-title":"Tomorrow\u2019s babies","author":"Lederberg","year":"1968"},{"key":"10.1016\/j.ymgme.2026.110257_bb0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/hum.1994.5.4-469","article-title":"An early history of gene transfer and therapy","volume":"5","author":"Wolff","year":"1994","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2026.110257_bb0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2014.08.001","article-title":"A longitudinal study of urea cycle disorders","volume":"113","author":"Batshaw","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110257_bb0040","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jimd.12100","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision","volume":"42","author":"Haberle","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.110257_bb0045","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1203\/00006450-199911000-00016","article-title":"Correction of ureagenesis after gene transfer in an animal model and after liver transplantation in humans with ornithine transcarbamylase deficiency","volume":"46","author":"Batshaw","year":"1999","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2026.110257_bb0050","series-title":"Comparing Treatment Options for Urea Cycle Disorders","author":"Ah Mew","year":"2020"},{"key":"10.1016\/j.ymgme.2026.110257_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.2443","article-title":"Are asymptomatic carriers of OTC deficiency always asymptomatic? A multicentric retrospective study of risk using the UCDC longitudinal study database","volume":"12","author":"Sen","year":"2024","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.ymgme.2026.110257_bb0060","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/mt.2011.32","article-title":"Induction and prevention of severe hyperammonemia in the spfash mouse model of ornithine transcarbamylase deficiency using shRNA and rAAV-mediated gene delivery","volume":"19","author":"Cunningham","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2026.110257_bb0065","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2014developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymgme.2026.110257_bb0070","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2026.110257_bb0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Kariko","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.ymgme.2026.110257_bb0080","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Kariko","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2026.110257_bb0085","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ymthe.2017.12.024","article-title":"Targeted mRNA therapy for ornithine transcarbamylase deficiency","volume":"26","author":"Prieve","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2026.110257_bb0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/hum.1990.1.3-241","article-title":"Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector","volume":"1","author":"Stratford-Perricaudet","year":"1990","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2026.110257_bb0095","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1203\/00006450-199704000-00012","article-title":"Adenovirus-mediated in vivo gene transfer rapidly protects ornithine transcarbamylase-deficient mice from an ammonium challenge","volume":"41","author":"Ye","year":"1997","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2026.110257_bb0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/10430340152712719","article-title":"A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency","volume":"13","author":"Raper","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2026.110257_bb0105","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110257_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2026.110257_bb0115","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","article-title":"AAV vectors: the Rubik\u2019s cube of human gene therapy","volume":"30","author":"Pupo","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2026.110257_bb0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ymthe.2006.03.009","article-title":"Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors","volume":"14","author":"Moscioni","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2026.110257_bb0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ymgme.2011.10.020","article-title":"Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genome","volume":"105","author":"Wang","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110257_bb0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymgme.2017.02.011","article-title":"AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice","volume":"120","author":"Wang","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110257_bb0135","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/mt.2009.88","article-title":"AAV2\/8-mediated correction of OTC deficiency is robust in adult but not neonatal Spf(ash) mice","volume":"17","author":"Cunningham","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2026.110257_bb0140","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/mt.2011.151","article-title":"AAV8-mediated hepatic gene transfer in infant rhesus monkeys (Macaca mulatta)","volume":"19","author":"Wang","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2026.110257_bb0145","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2026.110257_bb0150","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2026.110257_bb0155","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","article-title":"Patient-specific in vivo gene editing to treat a rare genetic disease","volume":"392","author":"Musunuru","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.110257_bb0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2026.110257_bb0165","doi-asserted-by":"crossref","first-page":"eabl9238","DOI":"10.1126\/scitranslmed.abl9238","article-title":"In vivo prime editing of a metabolic liver disease in mice","volume":"14","author":"Bock","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2026.110257_bb0170","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.ajhg.2023.10.005","article-title":"Efficient in vivo prime editing corrects the most frequent phenylketonuria variant, associated with high unmet medical need","volume":"110","author":"Brooks","year":"2023","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.110257_bb0175","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/s41551-025-01399-4","article-title":"Treatment of a metabolic liver disease in mice with a transient prime editing approach","volume":"9","author":"Rothgangl","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymgme.2026.110257_bb0180","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1126\/science.1078395","article-title":"Chimeric nucleases stimulate gene targeting in human cells","volume":"300","author":"Porteus","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2026.110257_bb0185","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr739","article-title":"Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting","volume":"39","author":"Cermak","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymgme.2026.110257_bb0190","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1093\/nar\/gkf495","article-title":"Mutations altering the cleavage specificity of a homing endonuclease","volume":"30","author":"Seligman","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymgme.2026.110257_bb0195","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2026.110257_bb0200","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2026.110257_bb0205","doi-asserted-by":"crossref","first-page":"10502","DOI":"10.1074\/jbc.TM118.000371","article-title":"How cells ensure correct repair of DNA double-strand breaks","volume":"293","author":"Her","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2026.110257_bb0210","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nbt.3469","article-title":"A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice","volume":"34","author":"Yang","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgme.2026.110257_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav7325","article-title":"Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates","volume":"11","author":"Milani","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2026.110257_bb0220","article-title":"A mutation-independent CRISPR-Cas9-mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency","volume":"6","author":"Wang","year":"2020","journal-title":"Sci. Adv."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:40:18Z","timestamp":1790368818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226005408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1096719226005408"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110257","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A brief history of gene therapy for ornithine transcarbamylase deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110257"}}